From Wall Street Beats to Biotech Breakthroughs
From Wall Street Beats to Biotech Breakthroughs
Podcast Description
In ”From Wall Street Beats to Biotech Breakthroughs,” Dean Zheng of Pfizer unpacks his unique path from DJing to pharma. Discover how AI is revolutionizing clinical trials, boosting efficiency, improving data quality, and accelerating drug development. Dean highlights innovative collaborations, showcasing AI’s real-world impact in healthcare.
Podcast Insights
Content Themes
The podcast explores themes around the intersection of technology and medicine, specifically focusing on artificial intelligence applications in healthcare. Notable episodes include discussions on AI's role in transforming clinical trial methodologies and enhancing patient outcomes, as well as deep dives into innovative partnerships between tech firms and pharmaceutical companies.
AI on the Hill is a podcast exploring the intersection of artificial intelligence, biotechnology, and clinical research. Designed to inform and inspire, the show brings together thought leaders, innovators, and regulatory voices to discuss frontier developments in AI-driven drug discovery, clinical trials, and health tech innovations.
Co-produced by Hill Research and the Tech Impact Foundation. Hill Research drives the advancement of AI in clinical trials, developing Generative AI solutions that optimize trial design, streamline operations, and improve regulatory outcomes, enabling faster delivery of life-changing therapies. Tech Impact Foundation advances the application of AI, biotechnology, and educational technology to improve human lives, promote knowledge sharing, and foster social equity through STEM education, public engagement, and investment in breakthrough research.
In this episode of AI on the Hill, host René Bastón sits down with Yaoyu Yang, Founder & CEO of Cypher AI, to explore one of the most fascinating questions of our time: Can AI truly be a scientist?
With over a decade at the intersection of biology and software, Yaoyu has built systems that redefine how experiments are designed and executed, from developing Aquarium at the University of Washington to architecting platforms at Ginkgo Bioworks, and now leading Cypher AI, where he’s building the world’s first AI software engineer for scientists.
Together, they discuss how human-in-the-loop AI is empowering, not replacing, researchers, what it means to turn pipettes into prompts, and how the future of discovery will depend on collaboration between human creativity and machine intelligence.
This episode dives deep into the evolving relationship between humans, AI, and science, and what it means to rethink intelligence itself.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.